Wissenschaftliche Publikationen Suche Suche Autor/in Forschungsgruppe Veröffentlichungsdatum Suchen Sortieren nach RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Reihenfolge AufsteigendAbsteigend Beule, Dieter Dr. (2) Cakmak-Görür, Nese Dr. (1) Daniel, Peter Prof. Dr. (1) Dhamodaran, Arunraj (1) Kammertöns, Thomas Dr. (3) Leisegang, Matthias Prof. Dr. rer. nat. (2) Lorenz, Felix Dr. (1) Marko, Lajos Dr. (1) Pezzutto, Antonio Prof. Dr. (2) Poncette, Lucia (1) Rhein, Simone Dr. (1) Siffrin, Volker (1) Uckert, Wolfgang Prof. Dr. (2) Willimsky, Gerald Dr. (2) (-) Blankenstein, Thomas Prof. Dr. (9) (-) Kopp, Joachim Dr. (1) Bioinformatics and Omics Data Science (1) Biologie maligner Lymphome (7) Genetik und Genomik von Herz- Kreislauferkrankungen (1) (-) Molekulare Immunologie und Gentherapie (9) Proteom Dynamik (1) Strukturbiologie Membran-assoziierter Prozesse (1) Systembiologie von Gen-regulatorischen Elementen (1) Translational Bioinformatics (2) 1992 (4) 1993 (7) 1994 (5) 1995 (8) 1996 (6) 1999 (2) 2000 (8) 2001 (5) 2002 (5) 2004 (8) 2005 (10) 2006 (1) 2007 (5) 2008 (5) 2009 (2) 2010 (7) 2011 (5) 2012 (6) 2013 (11) 2014 (3) (-) 2015 (3) 2016 (4) 2017 (6) 2018 (4) (-) 2019 (6) 2021 (4) 2022 (6) 2023 (4) 2024 (2) 9 Ergebnisse: Active Filter: Blankenstein, Thomas Prof. Dr.Kopp, Joachim Dr.Molekulare Immunologie und Gentherapie 20152019 Sortieren: Treffgenauigkeit Neueste nach älteste Älteste nach neueste 15. April 2015 / Int J Cancer Gene expression profiling of peripheral blood mononuclear cells during treatment with a gene-modified allogeneic tumor cell vaccine in advanced renal cell cancer: tumor-induced immunosuppression and a possible role for NF-κB A. Flörcken M. Grau A. Wolf A. Weilemann J. Kopp B. Dörken T. Blankenstein A. Pezzutto P. Lenz G. Lenz J. Westermann 01. April 2015 / Curr Opin Immunol Targeting cancer-specific mutations by T cell receptor gene therapy T. Blankenstein M. Leisegang W. Uckert H. Schreiber 01. April 2015 / Nat Biotechnol Identification of human T-cell receptors with optimal affinity to cancer antigens using antigen-negative humanized mice M. Obenaus C. Leitão M. Leisegang X. Chen I. Gavvovidis P. van der Bruggen W. Uckert D.J. Schendel T. Blankenstein 27. November 2019 / BMC Med Genomics Identification and ranking of recurrent neo-epitopes in cancer E. Blanc M. Holtgrewe A. Dhamodaran C. Messerschmidt G. Willimsky T. Blankenstein D. Beule 24. März 2019 / OncoImmunology Localization-associated immune phenotypes of clonally expanded tumor-infiltrating T cells and distribution of their target antigens in rectal cancer L. Penter K. Dietze J. Ritter M.F. Lammoglia Cobo J. Garmshausen F. Aigner L. Bullinger H. Hackstein S. Wienzek-Lischka T. Blankenstein M. Hummel K. Dornmair L. Hansmann 02. Januar 2019 / J Clin Invest Effective NY-ESO-1-specific MHC II-restricted T cell receptors from antigen-negative hosts enhance tumor regression L. Poncette X. Chen F.K.M. Lorenz T. Blankenstein 01. April 2019 / Leukemia Intracellular expression of FLT3 in Purkinje cells: implications for adoptive T-cell therapies N. Çakmak-Görür J. Radke S. Rhein E. Schumann G. Willimsky F.L. Heppner T. Blankenstein A. Pezzutto 02. September 2019 / BMC Bioinformatics SigsPack, a package for cancer mutational signatures F. Schumann E. Blanc C. Messerschmidt T. Blankenstein A. Busse D. Beule 07. Februar 2019 / Front Immunol Interferon-γ receptor signaling in dendritic cells restrains spontaneous proliferation of CD4(+) T cells in chronic lymphopenic mice L. Knop C. Frommer D. Stoycheva K. Deiser U. Kalinke T. Blankenstein T. Kammertoens I.R. Dunay T. Schüler
15. April 2015 / Int J Cancer Gene expression profiling of peripheral blood mononuclear cells during treatment with a gene-modified allogeneic tumor cell vaccine in advanced renal cell cancer: tumor-induced immunosuppression and a possible role for NF-κB A. Flörcken M. Grau A. Wolf A. Weilemann J. Kopp B. Dörken T. Blankenstein A. Pezzutto P. Lenz G. Lenz J. Westermann
01. April 2015 / Curr Opin Immunol Targeting cancer-specific mutations by T cell receptor gene therapy T. Blankenstein M. Leisegang W. Uckert H. Schreiber
01. April 2015 / Nat Biotechnol Identification of human T-cell receptors with optimal affinity to cancer antigens using antigen-negative humanized mice M. Obenaus C. Leitão M. Leisegang X. Chen I. Gavvovidis P. van der Bruggen W. Uckert D.J. Schendel T. Blankenstein
27. November 2019 / BMC Med Genomics Identification and ranking of recurrent neo-epitopes in cancer E. Blanc M. Holtgrewe A. Dhamodaran C. Messerschmidt G. Willimsky T. Blankenstein D. Beule
24. März 2019 / OncoImmunology Localization-associated immune phenotypes of clonally expanded tumor-infiltrating T cells and distribution of their target antigens in rectal cancer L. Penter K. Dietze J. Ritter M.F. Lammoglia Cobo J. Garmshausen F. Aigner L. Bullinger H. Hackstein S. Wienzek-Lischka T. Blankenstein M. Hummel K. Dornmair L. Hansmann
02. Januar 2019 / J Clin Invest Effective NY-ESO-1-specific MHC II-restricted T cell receptors from antigen-negative hosts enhance tumor regression L. Poncette X. Chen F.K.M. Lorenz T. Blankenstein
01. April 2019 / Leukemia Intracellular expression of FLT3 in Purkinje cells: implications for adoptive T-cell therapies N. Çakmak-Görür J. Radke S. Rhein E. Schumann G. Willimsky F.L. Heppner T. Blankenstein A. Pezzutto
02. September 2019 / BMC Bioinformatics SigsPack, a package for cancer mutational signatures F. Schumann E. Blanc C. Messerschmidt T. Blankenstein A. Busse D. Beule
07. Februar 2019 / Front Immunol Interferon-γ receptor signaling in dendritic cells restrains spontaneous proliferation of CD4(+) T cells in chronic lymphopenic mice L. Knop C. Frommer D. Stoycheva K. Deiser U. Kalinke T. Blankenstein T. Kammertoens I.R. Dunay T. Schüler